Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?

Recruiting

Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?

Sponsor:

University of Alberta

Code:

NCT05923970

Conditions

Vaccination Failure

Vaccine Response Impaired

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serology for antibody levels - Baseline

Serology to assess cell mediated immune (CMI) response - Baseline

Serology for antibody levels - Post third dose of MMR vaccine

Serology to assess CMI - Post third dose of MMR vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by University of Alberta on 2025-03-03.